We are live on ! Find out more
NAM

Nexpoint Asset Management Portfolio holdings

AUM $1.49B
1-Year Est. Return 61.08%
This Fund
S&P 500
This Quarter Est. Return
+21.63%
1 Year Est. Return
+61.08%
3 Year Est. Return
+208.69%
5 Year Est. Return
+685.71%
10 Year Est. Return
AUM
$304M
AUM Growth
-$138M
Cap. Flow
-$182M
Cap. Flow %
-60.02%
Top 10 Hldgs %
43.63%
Holding
203
New
45
Increased
4
Reduced
23
Closed
60

Sector Composition

Rank Sector Weight
1 Healthcare 16.91%
2 Energy 14.97%
3 Technology 14.48%
4 Real Estate 11.52%
5 Utilities 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRC
126
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$262K 0.09%
6,525
-36
-0.5% -$1.3K
COOLU
127
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
$261K 0.09%
+25,000
New +$260K
LXFR icon
128
Luxfer Holdings
LXFR
$457M
$244K 0.08%
14,890
TWCT
129
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
$240K 0.08%
+22,800
New +$229K
EBIX
130
DELISTED
Ebix Inc
EBIX
$203K 0.07%
5,343
-5,030
-48% -$141K
QSI icon
131
Quantum-Si Incorporated
QSI
$176M
$195K 0.06%
+19,200
New +$194K
NKTR icon
132
Nektar Therapeutics
NKTR
$2.51B
$170K 0.06%
667
ORGO icon
133
Organogenesis Holdings
ORGO
$208M
$151K 0.05%
+20,000
New +$95K
NERV icon
134
Minerva Neurosciences
NERV
$209M
$148K 0.05%
7,889
RP
135
PUT
DELISTED
RealPage, Inc.
RP
$140K 0.05%
+1,600
New +$105K
CTAQU
136
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$103K 0.03%
+10,000
New +$103K
GNW icon
137
Genworth Financial
GNW
$3.69B
$96K 0.03%
25,500
GNW icon
138
PUT
Genworth Financial
GNW
$3.69B
$96K 0.03%
25,500
ZAGG
139
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$95K 0.03%
+22,787
New +$79.8K
AGRX
140
DELISTED
Agile Therapeutics
AGRX
$72K 0.02%
13
YARW
141
Yarrow Bioscience, Inc. Common Stock
YARW
$113M
$64K 0.02%
11
NEX
142
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$64K 0.02%
18,749
EOLS icon
143
Evolus
EOLS
$485M
$34K 0.01%
10,000
ALGN icon
144
Align Technology
ALGN
$12.1B
-5,000
Closed -$1.64M
ALLY icon
145
Ally Financial
ALLY
$13.3B
-60,000
Closed -$1.5M
AMGN icon
146
Amgen
AMGN
$219B
-10,000
Closed -$2.54M
AWK icon
147
American Water Works
AWK
$26.9B
-10,000
Closed -$1.45M
BBY icon
148
Best Buy
BBY
$17.2B
-20,000
Closed -$2.23M
BFLY icon
149
Butterfly Network
BFLY
$2.28B
-99,534
Closed -$977K
BHR.PRB
150
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$51.5M
-1,173,758
Closed -$14.1M

Similar funds

Nexpoint Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Nexpoint Asset Management held 203 positions worth $304M, down 31% from $442M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Nexpoint Asset Management withdrew a net $182M in Q4 2020, closing 60 positions and reducing 23 holdings. Its most notable exit was Castle Biosciences, an estimated $36.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 20% a quarter earlier, followed by Energy and Technology.

Against the trend, Nexpoint Asset Management opened a new position in Tiffany & Co. worth $7.27M.

  • Nexpoint Asset Management's largest Q4 2020 buy was Tiffany & Co.: 55,283 shares worth $7.27M.
  • Nexpoint Asset Management added most to Advanced Micro Devices in Q4 2020, an estimated $604K increase.
  • Nexpoint Asset Management's biggest Q4 2020 reduction was Vistra, cutting an estimated $43M.
  • Nexpoint Asset Management fully exited Castle Biosciences in Q4 2020, selling an estimated $36.4M.
  • Nexpoint Asset Management's ten largest holdings make up 44% of its $304M portfolio in Q4 2020.
  • Nexpoint Asset Management opened 45 new positions and closed 60 in Q4 2020.
  • Nexpoint Asset Management's portfolio value fell 31% quarter-over-quarter to $304M.

Based on Nexpoint Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.